LIPE and cervical carcinoma: As for LIPE-AS1, Zhang et al. (30) reported that overexpression of LIPE-AS1 in cervical cancer can promote cell proliferation, migration, epithelial mesenchymal transition (EMT), and inhibit cell apoptosis, which can be reversed by LIPE-AS1 knockdown or mir-195-5p/mitogen activated protein kinase (MAPK) signaling pathway activation.